Letícia Queiroz Da Silva

Dr. Letícia Queiroz Da Silva

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LBLuis Fernando Bittar
Luis Fernando Bittar
LSLetícia Queiroz Da Silva
Letícia Queiroz Da Silva
FOFernanda Loureiro de Andrade Orsi
Fernanda Loureiro de Andrade Orsi
KZKiara Cristina Senger Zapponi
Kiara Cristina Senger Zapponi
BMBruna de Moraes Mazetto
Bruna de Moraes Mazetto
JAJoyce Maria Annichino-Bizzacchi
Joyce Maria Annichino-Bizzacchi
Post-thrombotic syndrome (PTS) is a limiting long-term complication present in 20–50% of patients with deep venous thrombosis (DVT) of the lower limbs. A panel of biomarkers with potential relevance to enhance knowledge on the pathophysiology of PTS was investigated. This case-control study included 93 patients with DVT in the lower limbs, 31 with severe PTS (cases) and 62 with mild/no PTS (controls), over 24 months after an acute episode. Thirty-one healthy individuals (HI) with no history of DVT were included as a reference to the population. FVIII activity, D-dimer, inflammatory cytokines, endothelial dysfunction markers, matrix metalloproteinases, and their inhibitors, tissue remodeling and growth factor levels were evaluated. The classification of PTS was, by the Villalta scale. Patients with severe PTS showed elevated levels of CRP, sICAM-1, sE-selectin, and decreased MMP-9 and MCP-1 levels when compared to patients with mild/no PTS. Moreover, DVT patients presented higher levels of FVIII and D-dimer when compared to HI. DVT patients present an inflammatory status, endothelial dysfunction and altered proteolysis MMPs activity, even a long time after the acute thrombotic episode, which is more significant in severe PTS. These results suggest a possible role of these mediators in the maintenance and worsening of PTS severity.

4 October 2018 in Regenerative Medicine
Verified
Journal Article
Closed access
LSLetícia Queiroz Da Silva
Letícia Queiroz Da Silva
SMSilmara Aparecida de Lima Montalvão
Silmara Aparecida de Lima Montalvão
AJAmauri da Silva Justo-Junior
Amauri da Silva Justo-Junior
JJJosé Luiz Rosenberis Cunha Júnior
José Luiz Rosenberis Cunha Júnior
SHStephany Cares Huber
Stephany Cares Huber
JAJoyce Maria Annichino-Bizzacchi
Joyce Maria Annichino-Bizzacchi
Aims: To compare levels and activity of the growth factors between fresh and lyophilized platelet-rich plasma (PRP). Methods: Analysis of platelet concentration using fibroblast and human umbilical vein endothelial cell cultures were compared between fresh and lyophilized PRP obtained from peripheral blood. Results: After lyophilization, 54% of platelets were intact whereas the fresh showed no aggregation with agonists (levels under 20%). The concentration of growth factors (VEGF, EGF, TGF-β and PDGF) in both products were similar. Fresh and lyophilized PRPs induced proliferation in the fibroblasts at 24 h (0.303 vs 0.300, respectively). Conclusion: Lyophilized PRP appears to be an alternative to fresh PRP and the results evidenced the role of growth factors as a key element in the activity of this product.

7 February 2021 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
LSLetícia Queiroz Da Silva
Letícia Queiroz Da Silva
RCRebeca Brito Bonani Cancela
Rebeca Brito Bonani Cancela
SMSilmara Aparecida de Lima Montalvão
Silmara Aparecida de Lima Montalvão
SHStephany Cares Huber
Stephany Cares Huber
GVGislaine Vieira-Damiani
Gislaine Vieira-Damiani
JAJoyce Maria Annichino-Bizzacchi
Joyce Maria Annichino-Bizzacchi

Verified
Journal Article
Open access
PDF file
LSLetícia Queiroz Da Silva
Letícia Queiroz Da Silva
TCThyerre Costa
Thyerre Costa
LMLucas Gelain Martins
Lucas Gelain Martins
SMSilmara Aparecida de Lima Montalvão
Silmara Aparecida de Lima Montalvão
SHStephany Cares Huber
Stephany Cares Huber
JAJoyce Maria Annichino-Bizzacchi
Joyce Maria Annichino-Bizzacchi
Deep venous thrombosis (DVT) is characterized by the formation of a thrombus within deep veins. The unmet need to identify new biomarkers and causal risk factors in DVT patients has led to the use of novel techniques, such as metabolite analyses. This study aimed to characterize metabolic alterations in acute DVT patients using 1H-NMR spectroscopy and determine the persistence of these changes over a six-month follow-up. Metabolomics, particularly 1H-NMR spectroscopy, was performed on serum samples from acute DVT patients (first 30 days from diagnosis) and healthy controls (HC). Additionally, 10 plasma markers were evaluated using a Luminex kit. A total of 30 patients, with a mean age of 44 ± 12.5 years, primarily women (9 males:21 females), were included. Acute DVT patients showed elevated inflammatory markers, such as IL-6, IL-8, PDGF-AB/BB, and P-selectin, which later decreased in the follow-up group. However, adhesion molecules like sVCAM-1 and sICAM-1 have increased after six months. Metabolomics analysis revealed significantly decreased levels of glutamine, glucose, and branched-chain amino acids (BCAAs), alongside increased lactate levels in acute DVT samples. Metabolomic profiles showed only partial normalization at follow-up, indicating persistent metabolic dysregulation. Overall, the reduced glucose metabolism and increased lactate levels indicate anaerobic metabolism, likely caused by tissue hypoxia due to impaired blood flow. Glutamine, essential for DNA, ATP, and protein synthesis, was notably reduced, potentially impairing endothelial cell proliferation and vascular repair. The presence of adhesion molecules in the follow-up group confirms persistent endothelial dysfunction. These findings suggest that metabolic and endothelial alterations may persist long after acute inflammation resolves in DVT patients. In conclusion, the persistence of metabolic dysregulation suggests chronic metabolic stress in these patients, potentially resulting from ongoing endothelial damage, low-grade inflammation, or altered mitochondrial function due to past tissue hypoxia.

16 March 2022 in Regenerative Medicine
Verified
Journal Article
Closed access
LSLetícia Queiroz Da Silva
Letícia Queiroz Da Silva
AJAmauri da Silva Justo-Junior
Amauri da Silva Justo-Junior
BMBeatriz de Moraes Martinelli
Beatriz de Moraes Martinelli
MCMárcio Alves da Cruz
Márcio Alves da Cruz
SHStephany Cares Huber
Stephany Cares Huber
JAJoyce Maria Annichino-Bizzacchi
Joyce Maria Annichino-Bizzacchi
Background: Platelet-rich plasma (PRP) has a high concentration of growth factors (GFs), which present a therapeutic wound healing effect. Despite having been correlated with an immunomodulatory fu... Plain language summary Platelet-rich plasma (PRP) contains growth factors, which stimulate normal wound healing. This product seems to be a good modulator of white blood cells and has not been inve...

1 February 2026 in The FASEB Journal
Verified
Journal Article
Open access
LSLetícia Queiroz Da Silva
Letícia Queiroz Da Silva
ASAlexander Leonardo Silva-Junior
Alexander Leonardo Silva-Junior
LSLicia C. Silva‐Costa
Licia C. Silva‐Costa
IBIvanio Teixeira Borba‐Junior
Ivanio Teixeira Borba‐Junior
BSBradley Joseph Smith
Bradley Joseph Smith
EPErich Vinicius De Paula
Erich Vinicius De Paula
Transient severe neutropenia and thrombocytopenia are frequent during treatment of hematological malignancies and contribute to early mortality through sepsis and bleeding. While neutrophils and platelets are essential for host defense and tissue repair, little is known about immune adaptations during their depletion. In this pilot, discovery phase study, we evaluated the plasma proteome of 10 patients with chemotherapy‐induced severe neutropenia and thrombocytopenia, prior to any clinical complication. At sampling, mean neutrophil and platelet counts were 0.15 ± 0.18 × 10 9 /L and 34.6 ± 17.4 × 10 9 /L, respectively. A total of 762 proteins were identified, of which 71 were downregulated and 21 were upregulated in patients compared with healthy controls. Over‐representation analyses revealed that most downregulated proteins were related to immune responses, hemostasis, and protein metabolism. Notably, six upregulated proteins (USP8, IGFBP2, RCN1, B2M, LRG1, and C9) also mapped to these pathways, supporting the hypothesis that they may contribute to early systemic responses to chemotherapy‐induced myelotoxicity and tissue damage. This exploratory study leveraged a unique clinical window to examine how the human immune system responds to the marked reduction of neutrophils and platelets in the context of tissue and barrier disruption. The downregulation profile suggests impairment of the host's immunothrombotic defense, whereas the upregulated proteins may represent early compensatory mechanisms aimed at preserving homeostasis. Together, these findings provide insights into systemic responses during profound cytopenias and highlight candidate proteins that may mediate early adaptations to hematopoietic and tissue injury in patients undergoing intensive chemotherapy.